Bibliography
Export 2842 results:
Candida albicans endocarditis associated with a contaminated aortic valve allograft--California, 1996. MMWR MorbMortalWklyRep. 1997;46(12):1.
Celiac disease transmitted by allogeneic non-T cell-depleted bone marrow transplantation. Bone marrow transplantation//Bone Marrow Transplant. 1997;20(7):607-9.
Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Cornea. 1997;16(2):132-7.
Comparison of cadaveric and living liver donors. Transplant Proc. 1997;29(8):3408-9.
Contamination of bone allografts: analysis of incidence and predisposing factors. J Bone Joint Surg Br. 1997;79(1):161-6.
Delayed hemolytic transfusion reaction due to anti-Js(a) in an alloimmunized patient with a sickle cell syndrome. American journal of clinical pathology//Am J Clin Pathol. 1997;108(6):658-61.
Development of Antibodies to Fetal Calf Serum With Arthus-Like Reactions
in Human Immunodeficiency Virus – Infected Patients Given Syngeneic Lymphocyte Infusions. Blood. 1997;89(3):6.
Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation. JAMA. 1997;277(2):133-7.
Disease transmission by means of allograft. J Burn Care Rehabil. 1997;18(1 Pt 2):S10-1.
Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant Team. Bone Marrow Transplant. 1997;19(7):685-689.
Donor origin of a posttransplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping. Transplantation. 1997;63(1):80-4.
Donor sepsis is not a contraindication to cadaveric organ donation. QJM. 1997;90(10):641-2.
Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantation. Bone Marrow Transplant. 1997;19(11):1155-6.
Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients. J Hepatol. 1997;26(4):926-34.
[Evaluation of the quality of life in patients with Chagas' disease undergoing a heart transplant]. Rev Soc Bras Med Trop. 1997;30(2):159-60.
Evaluation of transplant candidates with pre-existing malignancies. Ann Transplant. 1997;2(4):14-7.
The expanded donor. Transplant Rev. 1997;11:165.
Factors affecting donor-site morbidity after anterior cruciate ligament reconstruction using bone-patellar tendon-bone autografts. Knee Surg Sports Traumatol Arthrosc. 1997;5(4):222-8.
Factors influencing the suitability of organ-cultured corneas for transplantation. Invest Ophthalmol Vis Sci. 1997;38(1):16-24.
First report of invasive amebiasis in an organ transplant recipient. Transplantation. 1997;64(6):936-7.
Future shock: the long-term consequences of refractive surgery. Br J Ophthalmol. 1997;81(6):428-9.
GB hepatitis agent in cadaver organ donors and their recipients. Transplantation. 1997;63(3):346-51.
Grafting and the risk of hepatitis transmission: is there reason to be cautious? Are we cautious enough? Cornea. 1997;16(2):123-4.
Hepatitis G virus RNA and hepatitis G virus antibodies in renal transplant recipients: prevalence and risk factors. Transplantation. 1997;64(4):608-12.
Herpes simplex virus in primary graft failure. Arch Ophthalmol. 1997;115(5):586-9.